Concepedia

Ken Grime

KG

27

Publications

983

Citations

19

H-Index

2004

Active since

Affiliations

Loughborough University(Current)

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

AstraZeneca (Brazil)

Ken Grime is an author at Loughborough University specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2004–2025

27

Publications

27

Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo

Matthew G. Soars, Ken Grime, Joanne L. Sproston et al. · Drug Metabolism and Disposition · 2007 · 142 citations

EVALUATION OF TIME-DEPENDENT CYTOCHROME P450 INHIBITION USING CULTURED HUMAN HEPATOCYTES

Dermot F. McGinnity, Amanda J. Berry, Jane R. Kenny et al. · Drug Metabolism and Disposition · 2006 · 99 citations

AUTOMATED ASSESSMENT OF TIME-DEPENDENT INHIBITION OF HUMAN CYTOCHROME P450 ENZYMES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYSIS

Anthony C. Atkinson, Jane R. Kenny, Ken Grime · Drug Metabolism and Disposition · 2005 · 96 citations

Metabolic screening in vitro: metabolic stability, CYP inhibition and induction

Robert J. Riley, Ken Grime · Drug Discovery Today Technologies · 2004 · 56 citations

, , +10

Species Differences in Biliary Clearance and Possible Relevance of Hepatic Uptake and Efflux Transporters Involvement

Ken Grime, Stuart W. Paine · Drug Metabolism and Disposition · 2012 · 55 citations

Rows per page

1–5 of 27